Montelukast Therapy on Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

November 18, 2022

Study Completion Date

November 18, 2022

Conditions
Alzheimer Disease
Interventions
DRUG

Montelukast

"Participants in this arm will take a pill of Montelukast daily on escalating doses: 10, 20 to 40 mg.~All participants will be initiated on 10 mg. The dose will be increased in 2-week increments to 20 mg and 40 mg as long as participants report no intolerable symptoms or adverse events."

DRUG

Placebo oral tablet

Participants in this arm will take a matched placebo pill daily

Trial Locations (4)

30322

Emory Clinic, Atlanta

Emory University Hospital Clinical Research Network, Atlanta

30329

Executive Park, Atlanta

Wesley Woods, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT03991988 - Montelukast Therapy on Alzheimer's Disease | Biotech Hunter | Biotech Hunter